A Prospective Single-Center, Single-Arm, Open-Label, Phase II Study of Sintilimab and Anlotinib Combined with Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal Cancer
THORACIC CANCER（2024）
关键词
antiangiogenic,chemotherapy,neoadjuvant treatment,resectable esophageal cancer,sintilimab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要